Rewind Therapeutics has raised further funding that has seen Sunstone Life Science Ventures joining as a new investor. The funding round has seen participation of current investors Boehringer Ingelheim Venture Fund, M. Ventures, PMV, Gemma Frisius Fonds, and CD3/ KU Leuven.
/PRNewswire/ Rewind Therapeutics ("Rewind"), a private Belgian biotech company developing innovative first-in-class remyelinating therapies for multiple.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Quantum Drug Discovery Startup PolarisQB Announce Hiring of Pharmacologist Ian Reynolds
May 6, 2021 GMT
DURHAM, N.C., May 6, 2021 /PRNewswire/ Polarisqb is proud to add Dr. Ian Reynolds, a world renowned expert in pharmacology, as an advisor to the company. Dr. Ian Reynolds is an experienced pharmaceutical executive who has been recognized for his work in small molecule drug discovery and has helped a number ofacademic researchers translate into the world of biotech research and drug development.
Following a PhD. from Johns Hopkins in pharmacology and a postdoctoral fellowship in the University of Chicago’s Neuropharmacology department, Dr. Reynolds has been involved in a number of successful pharmaceutical ventures, including Knopp Biosciences and Teva Pharmaceuticals before taking over as the CEO of Belgium’s Rewind Therapeutics in 2018. He has studied a wide variety of Central Ner